Endovia Health Sciences (EDVA) Cash & Equivalents (2011 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Cash & Equivalents (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | 6.14 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 2.46 Bn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | 3.58 Bn |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | 1.72 Bn |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | 815.44 Mn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 5.10 Bn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 1.71 Bn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | 811.99 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 544.80 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | 242,702.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 242,702.00 |
| Mar 31, 2026 | 381,195.00 |
| Dec 31, 2025 | 281,435.00 |
| Sep 30, 2025 | 265,667.00 |
| Jun 30, 2025 | 17,213.00 |
| Dec 31, 2024 | 13,789.00 |
| Sep 30, 2024 | 456,889.00 |
| Jun 30, 2024 | 8,298.00 |
| Mar 31, 2024 | 14,757.00 |
| Dec 31, 2023 | 379,978.00 |
| Sep 30, 2023 | 96,121.00 |
| Jun 30, 2023 | 903,235.00 |
| Mar 31, 2023 | 2.15 Mn |
| Dec 31, 2022 | 4.43 Mn |
| Sep 30, 2022 | 2.60 Mn |
| Jun 30, 2022 | 4.21 Mn |
| Mar 31, 2022 | 8.50 Mn |
| Dec 31, 2021 | 4.18 Mn |
| Sep 30, 2021 | 8.14 Mn |
| Jun 30, 2021 | 11.94 Mn |